Abstract
PAF is a highly potent lipid mediator with diverse biological actions such as activation of platelets and leukocytes, induction of hypotension and bronchoconstriction (1). In earlier papers, we reported that PAF may play important roles in the pathogenesis of anaphylactic shock in mice and endotoxin shock and DIC in rats using the first PAF antagonist, CV-3988 (2–5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Braquet, P., Touqoui, L., Shen, T.Y. and Vargaftig, B.B. (1987) Pharmacol. Rev. 39: 97–145
Terashita, Z., Tsushima, S., Yoshioka, Y., Nomura, H., Inada. Y. and Nishikawa, K. (1983) Life Sci. 32: 1975–1982
Terashita, Z., Imura, Y., Nishikawa, K. and Sumida, S. (1985) Eur. J. Pharmacol. 109: 257–261
Terashita, Z., Imura, Y., Shino., A. and Nishikawa, K. (1987) J. Pharmacol. Exp. Ther. 243: 378–383
Imura, Y., Terashita, Z. and Nishikawa, K. (1986) Life Sci. 39: 111–117
Mullar-Berghaus, G. (1989) Semin. Thromb. Haemost. 15: 58–86
Carson S.D. (1984) Prog. Clin. Pathol. 9: 1–14
Terashita, Z., Kawamura, M., Takatani, M., Tushima, S., Imura, Y. and Nishikawa, K. (1992) J. Pharmacol. Exp. Ther. 260: 748–755
Stockmans, E, Arnout, J., Depre, M., Schepper, ED., Angehrn, J.C. and Vermylen, J. (1991) Thromb. Haemost. 65: 1108 P
Kawamura, M., Terashita, Z., Imura, Y., Shino, A. and Nishikawa, K. (1992) Thromb. Res. in the press.
Fukuda, C, lijima, K and Nakamura K (1989) Clin. Chem. 35: 1897–1990
Terashita, Z., Imura, Y. and Nishikawa, K. (1990) In: Handley, D.A., Saunders, R.N., Houlihan, W.J. and Tomesch, J.C. (Eds.) Platelet-activating factor in endotoxin and immune diseases. Marcel Dekker,Inc.New York. NY. pp 547–575
Pleszczynski, M.R. (1990) J. Lipd. Med. 2: S77 - S82
Rabinovici, R., Esser, K.M., Lysko, P.G., Yue, T., Grisworld, D.E. Hillegass, L.M., Bugelski, P.J., Hallenbeck, J.M. and Feurstein,G(1991) Circ.Res. 69: 12–25
Gilmore, M.A., Proc. Natl. Acad. Sci. U.S.A. (1986) 83: 4533–4537
Tanaka, M. (1989) Thromb. Res. 56: 201–211
Hirata, M., Shimomura, Y. and Yoshida, M. (1991) Thromb. Haemost. 65: 1107 P
Leaver, H.A., Qu, J.M., Smith, G., Howie, A., Ross, W.B. and Tap, P.L. (1990) Immunopharmacol. 20: 105–113
Barett, M.L., Lewis, G.P., Ward, S., Westwick, J. (1987) Br. J. Pharmacol 90: 113 P
Emeis, J.J. and Kluft, C. (1985) Blood 66: 86–91
Sakaguchi, K., Masugi, E, Chen, Y.H., Inoue, M., Ogihara, T. Yamada, K. and Yamastu, I. (1989) J. Lipid Med. 1: 171–173
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Japan
About this paper
Cite this paper
Terashita, Z., Kawamura, M., Imura, Y., Nishikawa, K. (1993). Possible Involvement of Platelet Activating Factor (PAF) in Tissue Factor Generation and the Pathogenesis of Disseminated Intravascular Coagulation (DIC). In: Shen, MC., Teng, CM., Takada, A. (eds) Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68323-0_10
Download citation
DOI: https://doi.org/10.1007/978-4-431-68323-0_10
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70123-1
Online ISBN: 978-4-431-68323-0
eBook Packages: Springer Book Archive